Comparative Study of the Efficacy of Either Krytantek Ofteno PF® or Eliptic Ofteno PF® Plus Gaap Ofteno PF® for POAG or Ocular Hypertension.

NCT04702789 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

28

Enrollment

INDUSTRY

Sponsor class

Stopped For interests of sponsor.

Conditions

Glaucoma, Open-Angle
Ocular Hypertension

Interventions

DRUG: Dorzolamide-timolol-brimonidine and latanoprost
DRUG: Dorzolamide-timolol and latanoprost

Sponsor

Laboratorios Sophia S.A de C.V.